Amgen (AMGN) EV to CFO (2009 - 2026)
Amgen (AMGN) posted EV to CFO of 45.42 for Q2 2026, down 44.1% on a QoQ basis from 81.25 in Q1 2026, and down 27.21% year-over-year from 62.4 in Q2 2025.
Analysis
Amgen (AMGN) EV to CFO (2009 - 2026) Analysis & Trends
Amgen has reported EV to CFO for 18 years, with the latest figure at 45.42 in Q2 2026.
- On a quarterly basis, EV to CFO fell 27.21% year-over-year to 45.42 in Q2 2026; TTM through Jun 2026 was 14.57, a 23.0% increase from a year earlier, with the FY2025 full-year figure at 16.79, up 50.79% from the prior year.
- EV to CFO was 45.42 for Q2 2026 at Amgen, down from 81.25 in the prior quarter.
- The five-year high for EV to CFO was 266.29 in Q4 2023, with the low at 20.57 in Q2 2023.
- Average EV to CFO over 5 years is 78.16, with a median of 59.54 recorded in 2022.
- The sharpest annual moves came in 2023 and 2024: EV to CFO surged 438.69% in 2023, then plunged 89.93% in 2024.
- Over 5 years, EV to CFO stood at 49.43 in 2022, then soared by 438.69% to 266.29 in 2023, then slumped by 89.93% to 26.82 in 2024, then soared by 288.95% to 104.32 in 2025, then sank by 56.46% to 45.42 in 2026.
- The last three EV to CFO figures came in at 45.42 (Q2 2026), 81.25 (Q1 2026), and 104.32 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn |
| 10 | BioNTech SE | 26.24 Bn | 12.58 Bn | 10.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 45.42 |
| Mar 31, 2026 | 81.25 |
| Dec 31, 2025 | 104.32 |
| Sep 30, 2025 | 30.43 |
| Jun 30, 2025 | 62.40 |
| Mar 31, 2025 | 114.10 |
| Dec 31, 2024 | 26.82 |
| Sep 30, 2024 | 45.98 |
| Jun 30, 2024 | 64.48 |
| Mar 31, 2024 | 207.26 |
| Dec 31, 2023 | 266.29 |
| Sep 30, 2023 | 39.52 |
| Jun 30, 2023 | 20.57 |
| Mar 31, 2023 | 91.70 |
| Dec 31, 2022 | 49.43 |
| Sep 30, 2022 | 36.53 |
| Jun 30, 2022 | 63.71 |
| Mar 31, 2022 | 56.67 |
| Dec 31, 2021 | 41.87 |
| Sep 30, 2021 | 44.35 |